Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$288.15Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 9/17/19
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$268.85 (100)
Ask (Size)$303.45 (100)
Day Low / HighN/A - N/A
Volume2.00

Regeneron Pharmaceuticals Says Trial Shows Efficacy in Genetic Cholesterol Disorder Treatment

11:47AM ET 8/14/2019 MT Newswires
Regeneron Pharmaceuticals (REGN) said it achieved positive phase 3 trial results for evinacumab, a monoclonal antibody that specifically binds to angiopoietin-like protein 3 (ANGPTL3), in patients with homozygous familial hypercholesterolemia ((HoFH), a genetic disorder wherein patients have a high level of bad cholesterol or LDL cholesterol.

Price: 299.48, Change: -5.38, Percent Change: -1.76